BioCryst Reports Second Quarter 2026 Financial Results
Go back to BioCryst Reports Second Quarter 2026 Financial Results| BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) | Delayed: 9.38 +0.08 (0.86%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.30 | 52 Week High | $10.98 | |||
| Open | $9.50 | 52 Week Low | $1.63 | |||
| Day High | $9.67 | P/E | N/A | |||
| Day Low | $9.23 | EPS | $-0.68 | |||
| Volume | 4,383,547 | |||||

